跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中打開
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
醫學工程學院
臺北醫學大學
電話
+886-2-27361661#7703
電子郵件
[email protected]
網站
http://bme.tmu.edu.tw/
郵寄地址
在地圖上顯示
No. 250 Wu-Xing Street
11031
Taipei
概覽
指紋
網路
專家檔案
(48)
專案
(638)
研究成果
(3717)
資料集
(88)
指紋
查看啟用 醫學工程學院 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
62%
Malignant Neoplasm
61%
Chitosan
36%
Randomized Controlled Trial
35%
Chronic Kidney Failure
35%
Rat
32%
Neoplasm
32%
Diseases
28%
Inflammation
27%
Hyaluronic Acid
23%
Cytotoxicity
22%
Breast Cancer
21%
Gelatin
20%
Liposome
20%
Fucoidan
18%
Hemodialysis
17%
Wound Healing
16%
Adverse Event
15%
Antiinfective Agent
14%
Antioxidant
13%
Photodynamic Therapy
13%
Anticarcinogen
13%
Polypyrrole
13%
Nanocarrier
12%
Mesoporous Silica Nanoparticle
12%
Osteoarthritis
12%
Diabetes Mellitus
12%
Placebo
12%
Epidermal Growth Factor Receptor
12%
Biocompatibility
12%
Reactive Oxygen Metabolite
12%
Doxorubicin
12%
Cerebrovascular Accident
11%
Cohort Study
11%
Growth Factor
11%
Leporidae
11%
Wound
10%
Chemotherapy Regimens
10%
Anti-Inflammatory Drug
10%
Infection
10%
Glucose
10%
Alginic Acid
10%
Drug Delivery System
9%
Microparticle
9%
Thrombocyte Concentrate
9%
Insulin
9%
Nanomaterial
9%
Polysaccharide
9%
Lipopolysaccharide
9%
Cell Viability
9%
Cytokine
9%
Rat Model
9%
Epigallocatechin Gallate
8%
Enzymes
8%
Side Effect
8%
Receptor
8%
Lung Cancer
8%
Drug Release
8%
IC50
8%
Hyperthermia
8%
Therapeutic Effect
8%
Cancer Growth
8%
Maturity Onset Diabetes of the Young
8%
Non Small Cell Lung Cancer
7%
Tumor Growth
7%
All Cause Mortality
7%
Messenger RNA
7%
Sleep Disordered Breathing
7%
Biomaterial
7%
Mouse Model
7%
Dry Eye
7%
Pharmacokinetics
7%
Curcumin
7%
Hydroxyapatite
7%
Clinical Trial
7%
Prevalence
7%
Glioblastoma
6%
Peptide
6%
Macrogol
6%
Tumor Necrosis Factor
6%
Polyethyleneimine
6%
End Stage Renal Disease
6%
Cyclooxygenase 2
6%
Biological Marker
6%
Colorectal Carcinoma
6%
Nanomedicine
6%
Carcinogenesis
6%
Vaccination
6%
Infectious Agent
6%
microRNA
6%
Calcium Phosphate
6%
Egg Lecithin
6%
Western Blot
6%
Pneumonia
6%
Micelle
6%
Keratin
5%
Random Effects Model
5%
Lipid
5%
Fibrinogen
5%
Thrombus
5%
Medicine and Dentistry
Meta-Analysis
100%
Systematic Review
75%
Randomized Controlled Trial
57%
Chronic Kidney Disease
29%
In Vitro
23%
Platelet
20%
Apoplexy
19%
Diseases
19%
Implant
19%
Magnetic Resonance Imaging
19%
Malignant Neoplasm
19%
Obstructive Sleep Apnea
17%
Knee
17%
Platelet Lysate
16%
Restylane
15%
Breast Cancer
15%
Cohort Analysis
15%
Odds Ratio
13%
Oral
12%
Finite Element Analysis
12%
Tricalcium Phosphate
11%
Hazard Ratio
11%
Wound Healing
10%
Artificial Intelligence
10%
Network Meta-Analysis
10%
Osteoporosis
10%
Cell Therapy
10%
Thrombocyte Rich Plasma
10%
COVID-19
9%
Pedicle
9%
Diabetes Mellitus
9%
Placebo
9%
Osseointegration
9%
Visual Analog Scale
9%
Mesenchymal Stem Cell
9%
Biological Marker
9%
Computer Assisted Tomography
9%
Infection
8%
Inflammation
8%
Clinical Trial
8%
Nanoparticle
8%
Thrombocyte Concentrate
8%
Adverse Event
8%
Spinal Cord Injury
8%
Neoplasm
8%
Bipolar Disorder
8%
Diabetes
8%
Injection
8%
Cancer
8%
End Stage Renal Disease
8%
Quality of Life
8%
Stem Cell
8%
Dry Eye
8%
Cancer Cell
7%
Maturity Onset Diabetes of the Young
7%
Prevalence
7%
Bone Graft
7%
Hemodialysis
7%
Orthopedics
7%
Retrospective Study
7%
Suture
7%
Dental Prosthesis
7%
Radiation Therapy
7%
Surgeon
7%
Lower Limb
7%
Oral Implants
7%
Biocompatibility
7%
Wound
7%
Acute Kidney Injury
7%
Gelatin
7%
Anterior Cruciate Ligament Reconstruction
7%
K-Complex
6%
Random Effects Model
6%
Programmed Cell Death
6%
Nephropathy
6%
Chitosan
6%
Tissue Regeneration
6%
Cardiovascular System
6%
Osteolysis
6%
Functional Electrical Stimulation
6%
Fibromyalgia
6%
Signal Transduction
6%
Health Care Cost
6%
Biocompatible Material
6%
Cartilage
6%
Tendon Graft
6%
Bleeding
6%
Electrotherapy
6%
Pelvis
6%
Spine Surgery
6%
Scanning Electron Microscopy
5%
Logistic Regression Analysis
5%
Hepatocellular Carcinoma
5%
Prediction Model
5%
Surgery
5%
Osteoarthritis
5%
Cell Viability
5%
Effect Size
5%
Chemotherapy
5%
Range of Motion
5%
Nursing and Health Professions
Meta Analysis
86%
Systematic Review
56%
Confidence Interval
37%
Cerebrovascular Accident
30%
Efficacy
25%
Chronic Kidney Failure
18%
Quality of Life
15%
Economic and Social Development
14%
Medline
14%
Accident Prevention
13%
Cochrane Library
13%
Sleep Disordered Breathing
12%
Pilot Study
11%
Prevalence
10%
Nurse
10%
Practice Guideline
10%
Hemodialysis
9%
Cross-Sectional Study
9%
Cohort Analysis
8%
Diseases
8%
Embase
8%
Breast Cancer
8%
Network Meta-Analysis
8%
Placebo
7%
Hazard Ratio
7%
Odds Ratio
7%
Health Care
7%
Clinical Trial
7%
Muscle
6%
Spinal Cord Injury
6%
Wound Healing
6%
Malignant Neoplasm
6%
Education
6%
Wearables
5%
Logistic Regression Analysis
5%
Adverse Event
5%
Postoperative Pain
5%
Long Term Care
5%
Sleep Quality
5%
Cardiovascular System
5%
Virtual Reality
5%
Injection
5%
Decision-Making
5%
Clinical Outcome
5%
Fibromyalgia
5%
Robotics
5%